AstraZeneca invests in Tregs

"One of the most promising UK biotech start-ups, Quell Therapeutics, has signed a research collaboration and licensing deal with AstraZeneca to develop treatments for two autoimmune diseases."

https://www.ft.com/content/92b0e9d5-22c1-4ddd-b135-52de8e200a48